A new method for the quantitative standardization of cross-sectional areas of the pulmonary arteries in congenital heart diseases with decreased pulmonary blood flow

…, H Kurosawa, K Tezuka, M Nakazawa, M Ando… - The Journal of thoracic …, 1984 - Elsevier
A new angiographic method for quantitative standardization of cross-sectional area of bilateral
pulmonary arteries, the PA-index, and retrospective analysis of the PA-index in different …

Predictive factors for interstitial lung disease, antitumor response, and survival in non–small-cell lung cancer patients treated with gefitinib

M Ando, I Okamoto, N Yamamoto, K Takeda… - Journal of Clinical …, 2006 - ascopubs.org
Purpose Interstitial lung disease (ILD) is a serious adverse effect of gefitinib, but its prevalence
and risk factors remain largely unknown. We examined the prevalence of and risk factors …

Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non–small-cell lung cancer: Results of the West Japan Thoracic Oncology …

…, T Sawa, I Goto, H Semba, T Seto, M Ando… - Journal of Clinical …, 2006 - ascopubs.org
Purpose Docetaxel has shown activity in elderly patients with advanced non–small-cell lung
cancer (NSCLC). This randomized phase III trial evaluated the efficacy and safety of …

Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia

Y Shindo, R Ito, D Kobayashi, M Ando… - American journal of …, 2013 - atsjournals.org
Rationale: Identification of patients with drug-resistant pathogens at initial diagnosis is
essential for treatment of pneumonia. Objectives: To elucidate clinical features of community-…

A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study

M Goto, K Wakai, T Kawamura, M Ando… - Nephrology Dialysis …, 2009 - academic.oup.com
Background. Immunoglobulin A nephropathy (IgAN) is the most common form of glomerulonephritis,
and a substantial number of patients succumb to end-stage renal disease (ESRD). …

[PDF][PDF] Randomized phase III trial of erlotinib versus docetaxel as second-or third-line therapy in patients with advanced non–small-cell lung cancer: Docetaxel and …

T Kawaguchi, M Ando, K Asami, Y Okano… - Journal of clinical …, 2014 - researchgate.net
… Takada, Koyo Hospital, Osaka; Masahiko Ando, Center for Advanced Medicine and …
Administrative support: Masahiko Ando, Shun-ichi Isa … Data analysis and interpretation …

Ultra-sensitive detection of the pretreatment EGFR T790M Mutation in non–small cell lung cancer patients with an EGFR-activating mutation using droplet digital PCR

M Watanabe, T Kawaguchi, S Isa, M Ando… - Clinical Cancer …, 2015 - AACR
Purpose: The resistance to the EGFR tyrosine kinase inhibitors (TKI) is a major concern in
non–small cell lung cancer (NSCLC) treatment. T790M mutation in EGFR accounts for nearly …

Ultrathin bronchoscopy with multimodal devices for peripheral pulmonary lesions. A randomized trial

M Oki, H Saka, M Ando, F Asano… - American Journal of …, 2015 - atsjournals.org
Rationale: The combination of an ultrathin bronchoscope, navigational technology, and
endobronchial ultrasound (EBUS) seems to combine the best of mutual abilities for evaluating …

Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non–small-cell lung cancer: results of …

I Okamoto, H Yoshioka, S Morita, M Ando… - Journal of clinical …, 2010 - ascopubs.org
Purpose The primary goal of this open-label, multicenter, randomized phase III trial was to
determine whether treatment with carboplatin plus the oral fluoropyrimidine derivative S-1 was …

Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing lung cancer: a randomized study

…, C Kitagawa, Y Kogure, N Murata, T Adachi, M Ando - Respiration, 2013 - karger.com
Background: Although rapid on-site cytologic evaluation (ROSE) is widely used during
endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), its role …